Similasan Eye Products Class Action Settlement

Similasan Eye Products Class Action Settlement

CLICK HERE TO ENTER

Click here to file a claim

The lawsuit alleges that Similasan covered products included in the settlement were deceptively labeled and advertised as homeopathic when the covered products had not secured the appropriate approvals from the Federal Food and Drug Administration (“FDA”), were not manufactured according to Current Good Manufacturing Practices, were misleadingly marketed as “sterile,” and failed to disclose the risk of silver sulfate. Claim forms must be submitted by October 15, 2025.

The covered products included in this settlement are the homeopathic eye products under the following brand names:

• Similasan Dry Eye Relief

• Similasan Complete Eye Relief

• Similasan Allergy Eye Relief

• Similasan Kids Allergy Eye Relief

• Similasan Red Eye Relief

• Similasan Pink Eye Relief

• Similasan Kids Pink Eye Relief

• Similasan Aging Eye Relief

• Similasan Computer Eye Relief

• Similasan Stye Eye Relief

• Similasan Pink Eye Nighttime Gel

• Similasan Dry Eye Nighttime Gel

• CVS Pink Eye Drops

• Walgreens Stye Eye Drops

• Walgreens Pink Eye Drops

• Walgreens Allergy Eye Drops

Who’s eligible:

• You are the class member if you purchased one of the Similasan, CVS or Walgreens Covered Products in the U.S. and/or the District of Columbia for personal use and not for resale, from September 11, 2017 until February 20, 2025

Potential Award Amount:

Proof of Purchase: Not required